Analyst Report: This Medical Cannabis Stock Is Projecting 740% Growth A STRONG BUY ALERT has been issued for this little known cannabis company. The perfect location geographically. The perfect partnerships. The perfect climate for their grow operations. Massive facilities. Technology that allows them to process pharmaceutical grade cannabis at half the cost of their competitors. According to analysts, these advantages could skyrocket this company to become a world leader in medical cannabis. |